Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study
During 2012-2021, GLP-1 RA use steadily increased across multinational cohorts of patients with T2D and CKD, and persistence with treatment was high. GLP-1 use was independent of CKD severity.
Authors
- Manel Pladevall (ORCID: https://orcid.org/0000-0002-9359-6055)
- Aníbal García‐Sempere (ORCID: https://orcid.org/0000-0002-4313-3976)
- Clara Rodríguez Bernal
- Christian Fynbo Christiansen (ORCID: https://orcid.org/0000-0002-0727-953X)
- F. Kristensen (ORCID: https://orcid.org/0000-0001-5311-8924)
- Alain Gay (ORCID: https://orcid.org/0000-0002-0689-7168)
- Natalie Ebert (ORCID: https://orcid.org/0000-0002-4463-3315)
- Alfredo E. Farjat (ORCID: https://orcid.org/0000-0001-6105-350X)
- Michael Walsh (ORCID: https://orcid.org/0000-0001-8292-2014)
- Naoki Kashihara (ORCID: https://orcid.org/0000-0002-9487-984X)
- Patrick O. Gee (ORCID: https://orcid.org/0000-0001-8442-481X)
- Catherine B. Johannes (ORCID: https://orcid.org/0000-0002-0586-9886)
- Suguru Okami (ORCID: https://orcid.org/0000-0003-4402-0209)
- Brenda N. Baak
- Isabel Hurtado (ORCID: https://orcid.org/0000-0002-8475-8112)
- David Vizcaya (ORCID: https://orcid.org/0000-0003-0248-7636)
- Hiroshi Kanegae (ORCID: https://orcid.org/0000-0001-5075-3594)
- Fernie J. A. Penning‐van Beest (ORCID: https://orcid.org/0000-0002-1906-9724)
- Anam Khan (ORCID: https://orcid.org/0000-0002-7827-6854)
- Ina Trolle Andersen (ORCID: https://orcid.org/0000-0002-8140-1548)
- Yuichiro Yano (ORCID: https://orcid.org/0000-0002-2565-7290)
- J. Bradley Layton (ORCID: https://orcid.org/0000-0003-0994-5820)
- Daniel Mines (ORCID: https://orcid.org/0000-0002-9134-2836)
- Reimar W. Thomsen (ORCID: https://orcid.org/0000-0001-9135-3474)
- Nikolaus G. Oberprieler
- Ryan Ziemiecki (ORCID: https://orcid.org/0000-0002-1774-7034)
- Craig I Coleman (ORCID: https://orcid.org/0000-0003-4868-7158)
- Ron M. C. Herings (ORCID: https://orcid.org/0000-0002-2561-8734)
- Csaba Pal Kovesdy (ORCID: https://orcid.org/0000-0002-8204-911X)
- Jetty A. Overbeek (ORCID: https://orcid.org/0000-0003-0935-5193)
- Fangfang Liu (ORCID: https://orcid.org/0000-0001-9792-1911)
- Satoshi Yamashita
- Celia Robles Cabaniñas
Institutions
- Hartford Hospital (US)
- National Kidney Foundation (US)
- University of Connecticut (US)
- Henry Ford Health System (US)
- University of Tennessee Health Science Center (US)
- Kawasaki Medical School (JP)
- Aarhus University Hospital (DK)
- Juntendo University (JP)
- Genki Plaza Medical Center for Health Care (JP)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- RTI Health Solutions (US)
- Pharmo Institute (NL)
- Hartford Financial Services (United States)
- Bayer (Germany) (DE)
- Charité - Universitätsmedizin Berlin (DE)
- McMaster University (CA)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1007/s13300-025-01717-8
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Bayer